---
$id: https://graph.org.ai/products/commodity/51172150
$type: Product
source: UNSPSC
code: "51172150"
title: "Talnetant"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Talnetant

**UNSPSC Code**: 51172150
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C25H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CZ3T9T146K, chemically known as 4-quinolinecarboxamide, 3-hydroxy-2-phenyl-n-(1-phenylpropyl)-, (s)- but generally known as talnetant, which bears US NIH Compound Identifier 133090. European Medicines Agency schedules Talnetant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34015. The term TALNETANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). Most nations schedule talnetant under HS 29334990 and SITC 51575. As of Q4 2014, TALNETANT remains the US FDA Preferred Term for this commodity. Talnetant bears US NLM identifiers UMLS ID C1701942 and NCI Concept Code C76464. SMILES: OC1C(C(=O)NC(CC)C2CCCCC2)C2C(NC1C1CCCCC1)CCCC2.

